Sniffing around here looking like a bottom, now with the PRV off the table, what catalyst are down the pipe? Looking at submission in early 2018 to the FDA, with approval, anyone think this could be back over a buck? What else is on the table?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.